FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3120447146> ?p ?o ?g. }

• W3120447146 endingPage "110" @default.
• W3120447146 startingPage "102" @default.
• W3120447146 abstract "•This meta-analysis supports the beneficial effect of TAVI in patients with bicuspid aortic stenosis (BAS) who are at increased risk of surgery. •There was no difference in overall mortality at 30-day or 1-year between BAS and tricuspid aortic stenosis patients who underwent TAVI. •Improved TAVI technology has increased procedural success with no difference in PVL rates between BAS and tricuspid aortic stenosis patients when using newer generation valves. •There was no difference in 30-day cardiovascular mortality, after-procedural major and/or life-threatening bleeding (BARC 3 or 5), major vascular complications, and AKI between the groups. •There is an increased incidence of stroke, conversion to surgery, and second valve implantation in patients with BAS. Most of the trials investigating the role of transcatheter aortic valve implantation (TAVI) across various strata of risk categories have excluded patients with bicuspid aortic stenosis (BAS) due to its anatomical complexities. The aim of this study was to perform a meta-analysis with meta-regression of studies comparing clinical, procedural, and after-procedural echocardiographic outcomes in BAS versus tricuspid aortic stenosis (TAS) patients who underwent TAVI. We searched the PubMed and Cochrane databases for relevant articles from the inception of the database to October 2019. Continuous and categorical variables were pooled using inverse variance and Mantel-Haenszel method, respectively, using the random-effect model. To rate the certainty of evidence for each outcome, we used the GRADE (Grading of Recommendations, Assessment, Development, and Evaluations) approach. Nineteen articles were included in the final analysis. There was no difference in the risk of 30-day mortality, 1-year mortality, 30-day cardiovascular mortality, major and/or life-threatening bleeding, major vascular complications, acute kidney injury, permanent pacemaker implantation, device success, annular rupture, after-procedural aortic valve area, and mean pressure gradient between the 2 groups. BAS patients who underwent TAVI had a higher risk of 30-day stroke, conversion to surgery, need for second valve implantation, and moderate to severe paravalvular leak. In conclusion, the present meta-analysis supports the feasibility of TAVI in surgically ineligible patients with BAS. However, the incidence of certain procedural complications such as stroke, conversion to surgery, second valve implantation, and paravalvular leak is higher among BAS patients compared with TAS patients, which must be discussed with the patient during the decision-making process. Most of the trials investigating the role of transcatheter aortic valve implantation (TAVI) across various strata of risk categories have excluded patients with bicuspid aortic stenosis (BAS) due to its anatomical complexities. The aim of this study was to perform a meta-analysis with meta-regression of studies comparing clinical, procedural, and after-procedural echocardiographic outcomes in BAS versus tricuspid aortic stenosis (TAS) patients who underwent TAVI. We searched the PubMed and Cochrane databases for relevant articles from the inception of the database to October 2019. Continuous and categorical variables were pooled using inverse variance and Mantel-Haenszel method, respectively, using the random-effect model. To rate the certainty of evidence for each outcome, we used the GRADE (Grading of Recommendations, Assessment, Development, and Evaluations) approach. Nineteen articles were included in the final analysis. There was no difference in the risk of 30-day mortality, 1-year mortality, 30-day cardiovascular mortality, major and/or life-threatening bleeding, major vascular complications, acute kidney injury, permanent pacemaker implantation, device success, annular rupture, after-procedural aortic valve area, and mean pressure gradient between the 2 groups. BAS patients who underwent TAVI had a higher risk of 30-day stroke, conversion to surgery, need for second valve implantation, and moderate to severe paravalvular leak. In conclusion, the present meta-analysis supports the feasibility of TAVI in surgically ineligible patients with BAS. However, the incidence of certain procedural complications such as stroke, conversion to surgery, second valve implantation, and paravalvular leak is higher among BAS patients compared with TAS patients, which must be discussed with the patient during the decision-making process." @default.
• W3120447146 created "2021-01-18" @default.
• W3120447146 creator A5000892801 @default.
• W3120447146 creator A5003312001 @default.
• W3120447146 creator A5004068726 @default.
• W3120447146 creator A5009937943 @default.
• W3120447146 creator A5049802550 @default.
• W3120447146 creator A5062606200 @default.
• W3120447146 creator A5068412285 @default.
• W3120447146 creator A5072525894 @default.
• W3120447146 creator A5073143520 @default.
• W3120447146 creator A5074546182 @default.
• W3120447146 creator A5075133520 @default.
• W3120447146 creator A5075356480 @default.
• W3120447146 creator A5085386621 @default.
• W3120447146 creator A5086890034 @default.
• W3120447146 date "2021-04-01" @default.
• W3120447146 modified "2023-10-03" @default.
• W3120447146 title "Meta-Analysis of Transcatheter Aortic Valve Implantation in Patients With Stenotic Bicuspid Versus Tricuspid Aortic Valve" @default.
• W3120447146 cites W1537972189 @default.
• W3120447146 cites W1854833362 @default.
• W3120447146 cites W2031630663 @default.
• W3120447146 cites W2033687467 @default.
• W3120447146 cites W2077666734 @default.
• W3120447146 cites W2087967794 @default.
• W3120447146 cites W2102129596 @default.
• W3120447146 cites W2134855279 @default.
• W3120447146 cites W2164686231 @default.
• W3120447146 cites W2586276406 @default.
• W3120447146 cites W2595545849 @default.
• W3120447146 cites W2740120589 @default.
• W3120447146 cites W2767486149 @default.
• W3120447146 cites W2773169111 @default.
• W3120447146 cites W2781562654 @default.
• W3120447146 cites W2793439509 @default.
• W3120447146 cites W2807780188 @default.
• W3120447146 cites W2809415387 @default.
• W3120447146 cites W2887602151 @default.
• W3120447146 cites W2905609438 @default.
• W3120447146 cites W2908083849 @default.
• W3120447146 cites W2915948736 @default.
• W3120447146 cites W2916914732 @default.
• W3120447146 cites W2922215374 @default.
• W3120447146 cites W2939213913 @default.
• W3120447146 cites W2950068502 @default.
• W3120447146 cites W2955739149 @default.
• W3120447146 cites W3006901445 @default.
• W3120447146 cites W3039911289 @default.
• W3120447146 cites W53141608 @default.
• W3120447146 doi "https://doi.org/10.1016/j.amjcard.2020.12.085" @default.
• W3120447146 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33460604" @default.
• W3120447146 hasPublicationYear "2021" @default.
• W3120447146 type Work @default.
• W3120447146 sameAs 3120447146 @default.
• W3120447146 citedByCount "7" @default.
• W3120447146 countsByYear W31204471462021 @default.
• W3120447146 countsByYear W31204471462022 @default.
• W3120447146 countsByYear W31204471462023 @default.
• W3120447146 crossrefType "journal-article" @default.
• W3120447146 hasAuthorship W3120447146A5000892801 @default.
• W3120447146 hasAuthorship W3120447146A5003312001 @default.
• W3120447146 hasAuthorship W3120447146A5004068726 @default.
• W3120447146 hasAuthorship W3120447146A5009937943 @default.
• W3120447146 hasAuthorship W3120447146A5049802550 @default.
• W3120447146 hasAuthorship W3120447146A5062606200 @default.
• W3120447146 hasAuthorship W3120447146A5068412285 @default.
• W3120447146 hasAuthorship W3120447146A5072525894 @default.
• W3120447146 hasAuthorship W3120447146A5073143520 @default.
• W3120447146 hasAuthorship W3120447146A5074546182 @default.
• W3120447146 hasAuthorship W3120447146A5075133520 @default.
• W3120447146 hasAuthorship W3120447146A5075356480 @default.
• W3120447146 hasAuthorship W3120447146A5085386621 @default.
• W3120447146 hasAuthorship W3120447146A5086890034 @default.
• W3120447146 hasConcept C126322002 @default.
• W3120447146 hasConcept C164705383 @default.
• W3120447146 hasConcept C2776570981 @default.
• W3120447146 hasConcept C2780007028 @default.
• W3120447146 hasConcept C2780714102 @default.
• W3120447146 hasConcept C2781355080 @default.
• W3120447146 hasConcept C2781414266 @default.
• W3120447146 hasConcept C2910672364 @default.
• W3120447146 hasConcept C71924100 @default.
• W3120447146 hasConcept C95190672 @default.
• W3120447146 hasConceptScore W3120447146C126322002 @default.
• W3120447146 hasConceptScore W3120447146C164705383 @default.
• W3120447146 hasConceptScore W3120447146C2776570981 @default.
• W3120447146 hasConceptScore W3120447146C2780007028 @default.
• W3120447146 hasConceptScore W3120447146C2780714102 @default.
• W3120447146 hasConceptScore W3120447146C2781355080 @default.
• W3120447146 hasConceptScore W3120447146C2781414266 @default.
• W3120447146 hasConceptScore W3120447146C2910672364 @default.
• W3120447146 hasConceptScore W3120447146C71924100 @default.
• W3120447146 hasConceptScore W3120447146C95190672 @default.
• W3120447146 hasFunder F4320332161 @default.
• W3120447146 hasFunder F4320337472 @default.
• W3120447146 hasLocation W31204471461 @default.
• W3120447146 hasOpenAccess W3120447146 @default.
• W3120447146 hasPrimaryLocation W31204471461 @default.

• next